Sharda Cropchem Limited
₹664.60-₹18.85 (-2.8%)
Last close · Data as of Oct 30, 2026
- Market cap
- ₹7,330 Cr
- P/E
- 17.9x
- EV / EBITDA
- 14.7x
- Revenue
- ₹3,661 Cr
- Net margin
- 5.3%
- ROCE
- 9.0%
Price chart
Technical chartScreen technicals →-24.6% over the last year
Daily closes.
Go deeper
Technical chart: candles, 9 moving averages, RSI, MACD and drawing tools
Performance
Price change over each period, before dividends.
- 1M
- -8.1%
- 3M
- -18.9%
- 6M
- -38.0%
- 1Y
- -24.6%
- 5Y
- +112.8%
52-week range
Day change -₹18.85 (-2.8%) from ₹683 to ₹665 · Last close Oct 30, 2026
Best weekday to invest, historically
The same weekly amount in SHARDACROP, bought on each weekday since 2021.
AI Summary
Indian StockStrengths1
- Revenue grew 40.6% YoY
Concerns1
- Low return on equity of 6.5%
Rule-based from financial data. Not advice.
About the company
Sharda Cropchem Limited, a crop protection chemical company, provides various formulations and generic active ingredients worldwide. It offers agrochemical products, including insecticides, fungicides, herbicides, veterinary drugs, plant growth regulators, fumigants, regulators, rodenticides, metalaxyl, propiconazole, phenthoate, pendimethalin, and dithianon; and biocides.
Read moreShow less
Sharda Cropchem Limited, a crop protection chemical company, provides various formulations and generic active ingredients worldwide. It offers agrochemical products, including insecticides, fungicides, herbicides, veterinary drugs, plant growth regulators, fumigants, regulators, rodenticides, metalaxyl, propiconazole, phenthoate, pendimethalin, and dithianon; and biocides. The company also provides conveyor belts, such as textile ply, rough top, steel cord, chevron/pattern, elevator, sidewall, pipe, and PVC/PVG solid woven conveyor belts, as well as cotton transmission belts, PVC and polyurethane light duty belting products, and V-belts. In addition, it offers industrial chemicals used in water treatment, food and food ingredients, and other industrial applications; and dyes and dye intermediates, as well as general chemicals. Further, the company supplies and distributes pharmaceuticals and intermediates products, including prothioconazole, azoxystrobin, P-nitrophenol - parathion-methyl, 2,4-dichloroacetophenone - propiconazole, cyclopropanecarboxylic acid - trinexapac-ethyl, and P-fluorobenzaledehyde - cyfluthrin. Sharda Cropchem Limited was founded in 1987 and is based in Mumbai, India.
- Sector
- Materials
- Shares outstanding
- 9.0 Cr shares
- ISIN
- INE221J01015
- BSE code
- 538666
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- ₹7,330 Cr
- P/E
- 17.9x
- P/B
- 3.0x
- EV / EBITDA
- 14.7x
- EV / Sales
- 2.6x
- P/S
- 2.8x
- Earnings yield
- 5.6%
- 52-week high
- ₹1,252.40
- 52-week low
- ₹630.55
Profitability
- Operating margin
- 7.4%
- Net margin
- 5.3%
- EBITDA margin
- 17.8%
- ROE
- 6.5%
- ROCE
- 9.0%
- ROA
- 3.6%
- Dividend payout
- 20.0%
- Tax rate
- 22.0%
- Other income, % of PBT
- 154.9%
Growth
- RevenueLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹3,661 Cr
- Revenue growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 40.6%
- Revenue CAGR, 5YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 10.0%
- EBITDALatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹463 Cr
- EBITDA growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- -31.6%
- Net profit growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 100.0%
- Net profit CAGR, 5YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- -6.5%
- Cash from operationsLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹163 Cr
- CFO growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 16.4%
- Free cash flowLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹32.0 Cr
- Asset growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- -4.6%
Solvency and efficiency
- Current ratio
- 1.67
- Debt / Equity
- 0.01
- Debt / Assets
- 0.00
- Debt / EBITDA
- 0.03
- Interest coverage
- 9.14
- Financial leverage
- 1.81
- CFO / Net profit
- 1.19
- Cash / Market cap
- 36.5%
- Cash per share
- ₹295.97
- Asset turnover
- 0.68
- Fixed asset turnover
- 3.68
- Capital intensity
- 0.27
- Debtor days
- 205 days
- Inventory turnover
- 2.19
- Cash conversion cycle
- 210 days
Where the revenue went
Of every ₹100 of FY2025 revenue, ₹7 was left as net profit.
| From | To | Amount |
|---|---|---|
| Sales | Expenses | ₹3,199 Cr |
| Sales | Operating profit | ₹462 Cr |
| Operating profit | Interest | ₹19 Cr |
| Operating profit | Depreciation | ₹275 Cr |
| Operating profit | Profit before tax | ₹168 Cr |
| Other income | Profit before tax | ₹175 Cr |
| Profit before tax | Tax and other | ₹69 Cr |
| Profit before tax | Net profit | ₹274 Cr |
Revenue and net profit
Revenue grew 40.6% in FY2025; net profit is the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2021 | ₹2,033 Cr | ₹210 Cr |
| FY2022 | ₹2,946 Cr | ₹283 Cr |
| FY2023 | ₹3,313 Cr | ₹325 Cr |
| FY2024 | ₹2,603 Cr | ₹137 Cr |
| FY2025 | ₹3,661 Cr | ₹274 Cr |
Cash flows
FY2025: ₹475 Cr from operations, ₹94.0 Cr free after investment (dashed).
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2021 | ₹202 Cr | -₹36 Cr |
| FY2022 | ₹277 Cr | ₹94 Cr |
| FY2023 | ₹140 Cr | ₹139 Cr |
| FY2024 | ₹163 Cr | -₹16 Cr |
| FY2025 | ₹475 Cr | ₹94 Cr |
Growth
Latest fiscal year FY2025 (ending March): each figure with its change over the year before.
- Revenue
- ₹3,661 Cr+40.6%1Y
- Net profit
- ₹274 Cr+100.0%1Y
- Cash from operations
- ₹475 Cr
- Free cash flow
- ₹94 Cr
- Revenue CAGR, 5Y
- 10.0%
- EBITDA CAGR, 5Y
- 5.2%
- Net profit CAGR, 5Y
- -6.5%
| Year | Revenue | Operating income | EBITDA | Net profit | CFO | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹3,661 Cr | ₹462 Cr | — | ₹274 Cr | ₹475 Cr | ₹94 Cr | 11.8% | +40.6% | +100.0% |
Monthly returns
Month-by-month returns of SHARDACROP across the years, with the seasonal pattern.
Balance sheet
What the company owns and owes at the end of FY2025.
| Line | FY2025 |
|---|---|
| Liabilities and equity | ₹4,387 Cr |
| Equity capital | ₹90 Cr |
| Reserves | ₹2,241 Cr |
| Borrowings | ₹8 Cr |
| Other liabilities | ₹2,048 Cr |
| Assets | ₹4,387 Cr |
| Fixed assets | ₹750 Cr |
| Capital work in progress | ₹291 Cr |
| Investments | ₹295 Cr |
| Other assets | ₹3,051 Cr |
Market cap against peers
8 peers: same sector group, nearest by size.
P/E against peers
SHARDACROP trades at 17.9x earnings against a peer median of 35.5x (a 50% discount).
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| Sharda Cropchem LimitedSHARDACROPthis companyP/E ↓ discount | ₹7,330 Cr | 17.9x | 3.0x | 6.5% | 14.7x |
| Birla Corporation Ltd.BIRLACORPN | ₹8,110 Cr | 28.4x | 1.4x | 3.5% | 14.0x |
| Kirloskar Ferrous Industries Ltd.KIRLFER | ₹7,675 Cr | 22.2x | 2.1x | 9.9% | 10.2x |
| Rashtriya Chemicals & Fertilizers LimitedRCF | ₹7,577 Cr | 24.5x | 1.5x | 4.9% | 12.9x |
| Sudarshan Chemical Indus. Ltd.SUDARSCHEM | ₹7,154 Cr | 36.2x | 3.0x | 30.3% | 12.1x |
| Elantas Beck India LtdELANTAS | ₹7,067 Cr | 51.2x | 7.6x | — | — |
| Gujarat Narmada Valley Fert.Co.LtdGNFC | ₹6,959 Cr | 11.2x | 0.8x | 5.9% | 6.3x |
| Gujarat State Fertilizers & Chem.LtdGSFC | ₹6,911 Cr | 10.8x | 0.6x | 4.2% | 6.6x |
| Galaxy Surfactants LimitedGALAXYSURF | ₹6,641 Cr | 41.1x | 4.4x | 14.2% | 19.2x |
| Peer median | — | 35.5x | 3.7x | 12.9% | 19.2x |
Year-to-date ROI
SHARDACROP since 1 January, against earlier years.
Historical volatility
SHARDACROP's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, in ₹ crore, grouped into plain-language lines.
Figures in ₹ crore as reported, fiscal years ending March, newest first; the trailing twelve months (TTM) last.
Operating margin by fiscal year
| Date | Operating margin |
|---|---|
| FY2021 | 19.0% |
| FY2022 | 20.0% |
| FY2023 | 15.0% |
| FY2024 | 7.0% |
| FY2025 | 13.0% |
| Line | FY2025 |
|---|---|
| RevenueSales | ₹3,661 Cr |
| Costs | |
| Interest | ₹19 Cr |
| Expenses | ₹3,199 Cr |
| Operating profitOperating Profit | ₹462 Cr |
| Other income and charges | |
| Profit before tax | ₹343 Cr |
| Tax | |
| Net profitNet Profit | ₹274 Cr |
| Per share |
| Line | FY2025 |
|---|---|
| Liabilities and equityTotal Liabilities | ₹4,387 Cr |
| Equity capitalEquity Capital | ₹90 Cr |
| Reserves | ₹2,241 Cr |
| Borrowings | ₹8 Cr |
| Other liabilitiesOther Liabilities | ₹2,048 Cr |
| AssetsTotal Assets | ₹4,387 Cr |
| Fixed assetsFixed Assets | ₹750 Cr |
| Capital work in progressCWIP | ₹291 Cr |
| Investments | ₹295 Cr |
| Other assetsOther Assets | ₹3,051 Cr |
| Line | FY2025 |
|---|---|
| Operating cash flowCash from Operating Activity | ₹475 Cr |
| Investing cash flowCash from Investing Activity | -₹381 Cr |
| Financing cash flowCash from Financing Activity | -₹62 Cr |
| Change in cashNet Cash Flow | ₹32 Cr |
Learn while you research
Academy chapters picked for Sharda Cropchem Limited and the metrics on this page.
- 01 Taxes on Investments (India)LTCG, STCG, dividend tax, what every Indian investor needs.6 min read
- 02 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 03 Growth Investing41% revenue growth is in the top tier, learn how to value growth.7 min read
- 04 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
- 05 Business Cycles & StocksThese cyclical sectors win and lose in different macro phases.6 min read
- 06 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read